|Bid||115.00 x 27700|
|Ask||115.35 x 21000|
|Day's range||115.35 - 118.10|
|52-week range||65.70 - 151.00|
|Beta (5Y monthly)||N/A|
|PE ratio (TTM)||N/A|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
Image source: The Motley Fool. MorphoSys AG (NASDAQ: MOR)Q1 2020 Earnings CallMay 9, 2020, 8:30 p.m. ETContents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks: OperatorLadies and gentlemen, welcome to MorphoSys First Quarter 2020 Results Conference Call.
MorphoSys (ETR:MOR) has had a great run on the share market with its stock up by a significant 24% over the last...
Morphosys' <MORG.DE> chief scientific officer will quit after 17 years with the group, the latest change at the top of the German biotech firm as it gears up for its first product launch. The group said late on Wednesday that CSO Markus Enzelberger would step down at the end of February to explore new opportunities. The shares dropped 2.1% at 0853 GMT on Thursday as one trader pointed to Enzelberger's "crucial position" at Morphosys.
MorphoSys AG (ETR:MOR) shareholders might be concerned after seeing the share price drop 10% in the last quarter. But...